startup pitch 2025

Berlin Heals has developed a novel implantable electroceutical device, called «C-MIC»: A small implantable device that propagates reverse remodeling of the cardiac muscle tissue by delivering a constant but minimal electrical direct current (DC) equivalent to physiological electrical currents in the heart.

As the acclaimed 2023 pitch competition winners, Retia Medical is redefining patient monitoring with its pioneering algorithms and equipment tailored for high-risk surgical and critical care patients. The Argos Cardiac Output Monitor, renowned for its precise Multi-Beat Analysis™, offers streamlined operation, rapid deployment, and a user-friendly interface, all while eliminating the need for expensive disposables. This innovation holds the promise of improved care for an estimated 20 million patients in surgical intensive care units globally. Rooted in White Plains, NY, Retia’s cutting-edge technology emerges from extensive research and development at Michigan State University and Massachusetts Institute of Technology, with its efficacy confirmed through comprehensive animal and human trials. Endorsed by a distinguished advisory board of industry and clinical leaders, Retia achieved FDA 510(k) clearance and introduced this breakthrough product in December 2018, setting a new standard in the management and support of critically ill patients.

Implandata Ophthalmic Products GmbH, the 2022 pitch competition winner, is at the forefront of digital health innovation in Hannover, Germany. Their groundbreaking approach integrates cutting-edge medical technology with advanced information systems to revolutionise glaucoma care. Their transformative solutions are designed to enhance therapy efficiency and improve outcomes for glaucoma patients and their loved ones, addressing the critical needs in a historically underserved sector.